Home › Funds › EVERETT HARRIS & CO /CA/ › LH

EVERETT HARRIS & CO /CA/ position in LH

LABCORP HOLDINGS INC · Health Care

EVERETT HARRIS & CO /CA/ reported holding 129,602 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$39.9M, representing 0.52% of its reported portfolio and ranking #28 among its reported holdings. EVERETT HARRIS & CO /CA/ has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)129.60K sh
Reported value held$39.93M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EVERETT HARRIS & CO /CA/'s LH position evolved

EVERETT HARRIS & CO /CA/ first disclosed a stake in LH in Q3 2023 at 13,513 shares (US$2.7M). The position peaked in Q3 2026 at 129,602 shares, worth US$39.9M. Across 13 filings, EVERETT HARRIS & CO /CA/ increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 129,602 shares valued at US$39.9M — an increase of 4,913 shares quarter over quarter.. Notable position changes include a 38% increase in Q4 2023 (shares fell 4% over the following quarter), a 47% increase in Q1 2026 (shares rose 5% over the following quarter), a 123% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.51K $2.72M New
Q4 2023 18.70K $4.25M Add
Q1 2024 23.58K $5.15M Add
Q2 2024 29.25K $5.95M Add
Q3 2024 30.51K $6.82M Add
Q4 2024 32.35K $7.42M Add
Q1 2025 32.54K $7.57M Add
Q2 2025 34.79K $9.13M Add
Q3 2025 34.28K $9.84M Reduce
Q4 2025 38.00K $9.53M Add
Q1 2026 55.94K $14.93M Add
Q2 2026 124.69K $34.91M Add
Q3 2026 129.60K $39.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has EVERETT HARRIS & CO /CA/ held LH?

EVERETT HARRIS & CO /CA/ has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EVERETT HARRIS & CO /CA/'s current position in LH?

As of Q3 2026, EVERETT HARRIS & CO /CA/ holds 129.60K shares of LH (LABCORP HOLDINGS INC), valued at $39.93M, representing 0.52% of its reported portfolio and ranking #28.

Has EVERETT HARRIS & CO /CA/ been buying or selling LH?

In the latest 13F filing (Q3 2026), EVERETT HARRIS & CO /CA/ increased its position in LH. The position peaked in Q3 2026 at 129.60K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.